✦ A U.S. district court ruled on July 31 that the Pharmaceutical Research and Manufacturers of America (PhRMA) can proceed with an amended lawsuit that challenges California’s law requiring drug manufacturers to provide advance notice and justification for price hikes, Stat reported. PhRMA contends that the law — which will remain intact while litigation continues — is unconstitutional. Two days earlier, California Attorney General Xavier Becerra said the state reached settlements with Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc. and Teikoku Pharma USA Inc. to resolve claims they engaged in “pay for delay” practices — when pharmaceutical firms pay generic drugmakers to delay bringing cheaper versions of branded drugs to the market. The three drugmakers will pay the state nearly $70 million.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.